Publications

Optimal environmental testing frequency for outbreak surveillance

Author(s): Olejarz JW, Oliveira Roster KI, Kissler SM, Lipsitch M, Grad YH|Journal: medRxiv| September 2023

Public health surveillance for pathogens presents an optimization problem: we require enough sampling to identify intervention-triggering shifts in pathogen epidemiology,…

Increased vaccine sensitivity of an emerging SARS-CoV-2 variant.

Author(s): Lewnard JA, Hong V, Kim JS, Shaw SF, Lewin B, Takhar H, Lipsitch M, Tartof SY|Journal: Nat Commun|PMID: 37386005| June 2023

Host immune responses are a key source of selective pressure driving pathogen evolution. Emergence of many SARS-CoV-2 lineages has been…

Geographic Targeting of COVID-19 Testing to Maximize Detection in Los Angeles County.

Author(s): Jia KM, Kahn R, Fisher R, Balter S, Lipsitch M|Journal: Open Forum Infect Dis|PMID: 37469616| June 2023

Many severe acute respiratory syndrome coronavirus 2 infections have not been detected, reported, or isolated. For community testing programs to…

What can be learned from viral co-detection studies in human populations

Author(s): Chin T, Foxman EF, Watkins TA, Lipsitch M|Journal: medRxiv| June 2023

When respiratory viruses co-circulate in a population, individuals may be infected with multiple pathogens and experience possible virus-virus interactions, where…

Defining and emulating target trials of the effects of postexposure vaccination using observational data

Author(s): Boyer CB, Lipsitch M|Journal: medRxiv| May 2023

In place of trials, investigators have used observational data to estimate the efficacy or optimal timing window for postexposure vaccines,…

Learning From COVID-19 to Improve Surveillance for Emerging Threats.

Author(s): Jernigan DB, George D, Lipsitch M|Journal: Am J Public Health|PMID: 36926966| May 2023

Estimated preventable COVID-19-associated deaths due to non-vaccination in the United States.

Author(s): Jia KM, Hanage WP, Lipsitch M, Johnson AG, Amin AB, Ali AR, Scobie HM, Swerdlow DL|Journal: Eur J Epidemiol|PMID: 37093505| April 2023

While some studies have previously estimated lives saved by COVID-19 vaccination, we estimate how many deaths could have been averted…

Alternative analysis of mpox vaccine effectiveness data from Israel

Author(s): Boyer CB, Lipsitch M|Journal: medRxiv| February 2023

Wolff Sagy et al. report that a single dose of MVA-BN mpox vaccine was 86% effective in preventing incident mpox.…

Fairness and efficiency considerations in COVID-19 vaccine allocation strategies: A case study comparing front-line workers and 65-74 year olds in the United States.

Author(s): Rumpler E, Feldman JM, Bassett MT, Lipsitch M|Journal: PLOS Glob Public Health|PMID: 36962865| February 2023

The COVID-19 epidemic in the United States has been characterized by two stark disparities. COVID-19 burden has been unequally distributed…

Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics.

Author(s): Joshi K, Rumpler E, Kennedy-Shaffer L, Bosan R, Lipsitch M|Journal: Vaccine|PMID: 36697312| January 2023

Vaccine allocation decisions during emerging pandemics have proven to be challenging due to competing ethical, practical, and political considerations. Complicating…